Nkarta News

Rodman & Renshaw Initiates Nkarta(NKTX.US) With Buy Rating, Announces Target Price $14

Moomoo NewsOct 9 07:35 ET

Nkarta Initiated With a Buy at Rodman & Renshaw

TipRanksOct 9 06:47 ET

Mizuho Securities Maintains Nkarta(NKTX.US) With Buy Rating, Cuts Target Price to $20

Moomoo NewsAug 16 09:31 ET

A Quick Look at Today's Ratings for Nkarta(NKTX.US), With a Forecast Between $13 to $22

Moomoo NewsAug 15 09:00 ET

A Quick Look at Today's Ratings for Nkarta(NKTX.US), With a Forecast Between $13 to $22

Moomoo NewsAug 14 09:00 ET

Nkarta Price Target Maintained With a $13.00/Share by Needham

Dow JonesAug 14 06:06 ET

Nkarta Analyst Ratings

BenzingaAug 14 05:48 ET

TD Cowen Remains a Buy on Nkarta (NKTX)

TipRanksAug 13 19:27 ET

HC Wainwright & Co. Reiterates Buy on Nkarta, Maintains $23 Price Target

BenzingaJul 24 15:07 ET

Nkarta Analyst Ratings

BenzingaJul 24 15:06 ET

H.C. Wainwright Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsJul 24 10:33 ET

Buy Rating Confirmed: Expanding Potential of Nkarta's NKX019 in SLE Treatment

TipRanksJul 24 09:42 ET

Nkarta Analyst Ratings

BenzingaJun 27 13:50 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH), Atara Biotherapeutics (ATRA) and Nkarta (NKTX)

TipRanksMay 15 22:15 ET

Nkarta Analyst Ratings

BenzingaMay 13 13:34 ET

Nkarta Analyst Ratings

BenzingaMay 10 14:41 ET

Nkarta Inc. Buy Rating Affirmed Amidst Promising Clinical Studies and Robust Financial Health

TipRanksMay 10 06:40 ET

Buy Rating Affirmed: Nkarta's NKX019 Shows Promise in Lupus Nephritis Clinical Trials

TipRanksMay 10 06:36 ET

William Blair Remains a Buy on Nkarta (NKTX)

TipRanksMay 9 22:01 ET

Nkarta Analyst Ratings

BenzingaApr 10 07:33 ET